Darifenacin hydrobromide

• CAT Number: A001081
• CAS Number: 133099-07-7
• Molecular Formula: C28H31BrN2O2
• Molecular Weight: 507.46
• Purity: ≥95%
• Synonyms: 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide
• InChI: InChI=1S/C28H30N2O2.BrH/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26;/h1-12,19,25H,13-18,20H2,(H2,29,31);1H/t25-;/m1./s1
• InChIKey: UQAVIASOPREUIT-VQIWEWKSSA-N
• SMILES: C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br

Darifenacin hydrobromide(CAT: A001081) is a selective muscarinic M3 receptor antagonist widely studied in pharmacological and clinical research. By blocking M3 receptors in smooth muscle, it reduces involuntary bladder contractions, making it a key compound for investigating overactive bladder and related urological disorders. Its high receptor selectivity provides an important tool for exploring cholinergic signaling pathways without broad off-target effects typical of non-selective antimuscarinics. Beyond urology, Darifenacin hydrobromide supports studies in neurological and metabolic disease models where muscarinic pathways influence cellular function. This compound is also valuable in drug development research as a reference standard for antimuscarinic therapies.